#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Partial lipodystrophy Acute myeloid leukaemia refractory Duchenne muscular dystrophy gene carrier Renal disorder Cardiac sarcoidosis Juvenile chronic myelomonocytic leukaemia Ovarian cancer Angiosarcoma metastatic Oropharyngeal cancer recurrent Anti-neutrophil cytoplasmic antibody positive vasculitis Ovarian cancer stage III Von Hippel-Lindau disease Hypoparathyroidism Arginase deficiency Acute graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Diagnostics Osteosarcoma recurrent Alveolar rhabdomyosarcoma – Life with Disease Adrenogenital syndrome – Basic Information Anaplastic thyroid cancer – Basic Information Hairy cell leukaemia Brain stem glioma – Trials in Disease Mucopolysaccharidosis II – Life with Disease Idiopathic pulmonary fibrosis – Diagnostics Richter’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bemcentinib Bortezomib Arrhenatherum Elatius Buparlisib Ketamine Hydrochloride Lasn01 Ocrelizumab Cortisone Sodium Alginate Asfotase Alfa Betibeglogene Autotemcel Opium, Standardized Powdered Imipenem Monohydrate Ep0042 Tamuzimod Acetate Ipatasertib Darunavir CIRTUVIVINT Fenfluramine Hydrochloride Eo2318 More therapies…

    Learn about Your Condition

    Immunodeficiency congenital Oropharyngeal cancer Adenocarcinoma gastric Metastasis Strongyloidiasis Angiosarcoma recurrent Abdominal pain Carpal tunnel syndrome Mental disorder Diabetic retinal oedema Leukaemia Soft tissue sarcoma Acquired haemophilia Irritable bowel syndrome Anxiety More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Intensive care

  • Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dalteparin Sodium
    • Enoxaparin Sodium
    • Human Albumin Solution
    Denmark Finland Iceland The Netherlands Sweden

  • Study on Amoxicillin and Clavulanic Acid for Treating Ventilator-Associated Pneumonia in Intensive Care Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    France

  • Study on Fish Oil Emulsion for Preventing Atrial Fibrillation in High-Risk Cardiac Surgery Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Highly Refined Fish Oil
    • Purified Egg Phospholipids
    • Glycerol
    Germany

  • Study on Dexamethasone Phosphate for Reducing Breathing Problems in Children with Upper Airway Obstruction in Intensive Care

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    France

  • Study of dexmedetomidine compared to midazolam to reduce delirium in critically ill children on breathing machines in intensive care

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexmedetomidine
    • Midazolam
    France

  • Study on Opioid-Free Pain Relief for ICU Patients on Ventilators Using Nefopam Hydrochloride, Paracetamol, and Ketamine Hydrochloride

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Nefopam Hydrochloride
    • Remifentanil Hydrochloride
    • Tramadol Hydrochloride
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!